- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Leaders sound off on overrated ASC trends
- GLP-1s and cancer outcomes: What new research shows
- Private equity targets pain management: 5 things to know
- Parkinson’s drug development halted after midstage trial failure
- Houlton Regional nurses plan 4-day strike
- HHS watchdog finds 6 Part D plans accounted for 82% of 2023’s $276B gross federal spend
- 15 women making moves in healthcare
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- Pioneer of sight-giving surgeries, ambulatory leader dies at 94
- 20 most trusted health system brands
- Allstate targets ASCs in fraud blitz: 3 federal lawsuits in 5 weeks
- 10 highest-paying states for dental hygienists in 2026
- How hospitals are fending off a retirement wave
- 10 hospitals with longest ED visit times, per CMS
- Employer health costs jump 7.9%: 5 report findings
- Abridge names chief technology officer
- Mayo Clinic to build 128K-square-foot surgical center
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- 4 anesthesiologists in the headlines
- Data breaches, restructurings & more: 8 DSOs making headlines
- Lee Health acquires independent physician practice, ASC
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan aesthetics unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Severe Asthma Often Comes With Other Serious Health Problems
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- APRN charged in $1.35M Medicare fraud scheme
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- ASCs’ volume trap: Why more cases can mean less profit
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Is the ‘legal dinosaur’ of Stark law doing more harm than good?
- The biggest disruptors to DSO growth
- How the top DSOs are pulling ahead of the pack
- 5 DSOs making moves out West
- The DSO rebound
- Oral surgeon pay by state, adjusted for cost of living
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- UHS behavioral health president resigns
- Psychiatrist pay by state, adjusted for cost of living
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- Watch: The Tug-of-War Over Taxpayer Dollars
- Labcorp joins lab results personalization push with ‘MyLabcorp’ AI app
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- AI company Commure banks $70M funding round, hits $7B valuation
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Coalition of attorneys general sue to block federal student loan caps
- The broken pipeline of mental healthcare for LGBTQ teenagers
- Listen to the Latest ‘KFF Health News Minute’
- Reduced average length of stay salvaged hospitals' operating margins in March: report
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Roche signs generic Xofluza licensing deal with Medicines Patent Pool for 129 countries
- UCB digs deeper into Bimzelx’s psoriatic arthritis win over Skyrizi
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Doximity inks partnerships with Aledade, Photon as it ramps up AI spending in 2026
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
- Pregnancy Safe For Women With Myasthenia Gravis, Study Concludes
- BeOne kicks off ‘One Save Changes Everything’ campaign with Tim Howard
Barry Cadden, the former President of New England Compounding Center (NECC), was given a 10- to 15-year sentence by Judge Matthew McGivney, the Chief Judge for the 44th Circuit Court in Livingston County, Michigan:
Pharmacy exec sentenced in Michigan over deadly 2012 meningitis outbreak
By Nate Raymond - May 10, 2024May 10 (Reuters) - A former owner of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly U.S. fungal meningitis outbreak in 2012 was sentenced on Friday to at least 10 years in prison for his role in the deaths of 11 Michigan residents.
Barry Cadden, the former president of New England Compounding Center (NECC), was sentenced by Judge Matthew McGivney in Howell, Michigan, after pleading no contest in March to involuntary manslaughter charges related to the 11 deaths.
The 10- to 15-year sentence will run concurrently with an already-imposed 14-1/2 year federal prison term that Cadden, 57, is serving after he was convicted in 2017 on racketeering and fraud charges related to misrepresentations he made to NECC customers about its drugs.
Federal prosecutors in Boston had also sought to convict Cadden of second-degree murder over 25 deaths nationally caused by mold-tainted steroids that Framingham, Massachusetts-based NECC produced. Jurors acquitted Cadden of those charges.
Michigan's attorney general subsequently brought charges in state court against Cadden and Glenn Chin, NECC's former supervisory pharmacist, who like Cadden was convicted of federal fraud charges but cleared at trial of second-degree murder.
"The families of these 11 victims will forever bear the weight of Mr. Cadden's greed and disregard for basic standards that caused this horrific tragedy," Michigan Attorney General Dana Nessel said in a statement.
Prosecutors said NECC produced the drugs in filthy and unsafe conditions and sold them to hospitals and clinics nationally. The outbreak sickened 793 patients, more than 100 of whom have died, federal prosecutors have said.
Cadden's sentence on Friday credited him for the more than 6-1/2 years he has already spent in custody, according to his lawyer, Gerald Gleeson. He had no further comment.
Charges in Michigan remain pending against Chin, who has pleaded not guilty and is serving a 10-1/2 year federal sentence.
Glenn Chin was the supervising pharmacist of the New England Compounding Center (NECC); an employee of Barry Cadden, the former President, who got a dime piece earlier this month:
Trial Date Set for Man Charged with Murder in Livingston County Fungal Meningitis Outbreak
By Danny Wimmer - May 20, 2024LANSING – Judge Matthew J. McGivney in the 44th Circuit Court in Livingston County set the trial for Glenn Chin, 56, of Canton, Massachusetts, for November 4, 2024. Chin faces 11 counts of second-degree murder for his alleged involvement in the deadly 2012 fungal meningitis outbreak.
“Eleven Michiganders tragically lost their lives as a result of a lack of concern for patient safety,” Nessel said. “My department looks forward to finally seeking justice for the victims and their families in court.”
Chin was the supervising pharmacist at the New England Compounding Center (NECC) in Framingham, Massachusetts. In 2012, a nationwide fungal meningitis outbreak resulted in 64 deaths, 11 of which occurred at the Michigan Pain Specialists Clinic (MPS) in Livingston County. Patients at the clinic were given epidural injections of the steroid methylprednisolone, which was compounded and produced at the NECC in Massachusetts and shipped to MPS. Donna Kruzich, Paula Brent, Lyn Laperriere, Mary Plettl, Gayle Gipson, Patricia Malafouris, Emma Todd, Jennie Barth, Ruth Madouse, Salley Roe, and Karina Baxter died as a result of being injected with the contaminated drug.
The Department alleges that Chin disregarded sterility procedures in the compounding of sterile medications, created fraudulent cleaning records, and falsified scientific testing results.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
